Reducing the Effective Specific Activity of [225Ac]-PSMA-617 to Minimize Salivary Gland and Renal Toxicity

被引：0
|
作者：
Esposito, T. [1 ]
Kalidindi, T. [1 ]
Payne, R. [1 ]
Faudemer, Z. [1 ]
Jones, K. [1 ]
Pillarsetty, N. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-770
引用
收藏
页码：S344 / S344
页数：1
相关论文
共 16 条
  • [1] Synthesis of [225Ac]PSMA-617 for preclinical evaluation
    Sowa, Alexandra
    Rodnick, Melissa
    Piert, Morand
    Scott, Peter
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [2] Radiolabelling of different quantities of PSMA-617 with 225Ac: the more the better?
    Esposito, A.
    Buonanno, M. J.
    Aurilio, M.
    Squame, E.
    Morisco, A.
    Maisto, C.
    Porfidia, V.
    de Marino, R.
    Lastoria, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S842 - S842
  • [3] Hematological Toxicity of [177Lu]Lu-PSMA-617 and [225Ac]Ac-PSMA-617 in RM1-PGLS syngeneic mouse model
    Vilangattil, Meryl Maria
    Swaidan, Abir
    Godinez, Jonathan
    Taddio, Marco
    Czernin, Johannes
    Mona, Christine
    Carlucci, Giuseppe
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [4] Hematological toxicity of [225Ac]Ac-PSMA-617 and [177Lu]Lu-PSMA-617 in RM1-PGLS syngeneic mouse model
    Meryl Maria Vilangattil
    Abir Swaidan
    Jonathan Godinez
    Marco F. Taddio
    Johannes Czernin
    Christine E. Mona
    Giuseppe Carlucci
    EJNMMI Radiopharmacy and Chemistry, 10 (1)
  • [5] Comparison of PSMA-TO-1 and PSMA-617 labelled with 68Ga, 177Lu and 225Ac: a first in-human translational study
    Meyer, C.
    Prasad, V.
    Stuparu, A.
    Glatting, G.
    Kletting, P.
    Miksch, J.
    Solbach, C.
    Lueckerath, K.
    Nyiranshuti, L.
    Zhu, S.
    Czernin, J.
    Dahlbom, M.
    Calais, J.
    Beer, A.
    Slavik, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S43 - S43
  • [6] Combined PRLT using Ac-225 and Lu-177 labeled PSMA-617 (TANDEM-PRLT) in end-stage metastatic prostate cancer: a concept to reduce salivary gland toxicity?
    Langbein, T.
    Kulkarni, H. R.
    Singh, A.
    Schuchardt, C.
    Zhang, J.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S645 - S645
  • [7] Combined PRLT using Ac-225 and Lu-177 labeled PSMA-617 (TANDEM-PRLT) in end-stage metastatic prostate cancer: a concept to reduce salivary gland toxicity?
    Langbein, Thomas
    Kulkarni, Harshad
    Singh, Aviral
    Schuchardt, Christiane
    Zhang, Jingjing
    Baum, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [8] Botulinum toxin plus transdermal scopolamine reduce salivary gland uptake of 225Ac/177Lu-PSMA ligands
    Zhang, J.
    Mueller, J.
    Fan, X.
    Zhao, T.
    Jakobsson, V.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S360 - S361
  • [9] Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing 225Ac-PSMA-617 RLT
    Hendrik Rathke
    Clemens Kratochwil
    Ralph Hohenberger
    Frederik Lars Giesel
    Frank Bruchertseifer
    Paul Flechsig
    Alfred Morgenstern
    Matti Hein
    Peter Plinkert
    Uwe Haberkorn
    Olcay Cem Bulut
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 139 - 147
  • [10] Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing 225Ac-PSMA-617 RLT
    Rathke, Hendrik
    Kratochwil, Clemens
    Hohenberger, Ralph
    Giesel, Frederik Lars
    Bruchertseifer, Frank
    Flechsig, Paul
    Morgenstern, Alfred
    Hein, Matti
    Plinkert, Peter
    Haberkorn, Uwe
    Bulut, Olcay Cem
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (01) : 139 - 147
12